Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor

case report.

T. M. Durham, E. D. Hodges, James Lloyd Harper, J. G. Green, F. Tennant

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

This report describes identification of Factor VIII inhibitor in a patient who then received immune tolerance therapy. The precipitating event was a traumatic orofacial injury that was nonresponsive to traditional factor-replacement therapies. An inhibitor complicates medical and dental management of the hemophiliac patient because it counteracts usual techniques of hemorrhage control using coagulation agents derived from Factor VIII (Monoclate--Armour, Blue Bell, PA). Successful identification and management of the inhibitor patient require communication and consultation between the physician and dentist, up-to-date knowledge regarding the hemophiliac patient's bleeding and infusion history and aggressive application of local adjunctive hemostatic therapies.

Original languageEnglish (US)
Pages (from-to)282-287
Number of pages6
JournalPediatric dentistry
Volume15
Issue number4
StatePublished - Jul 1 1993

Fingerprint

Facial Injuries
Factor VIII
Hemorrhage
Immune Tolerance
Hemostatics
Dentists
Tooth
Therapeutics
Referral and Consultation
History
Communication
Physicians
Wounds and Injuries

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor : case report. / Durham, T. M.; Hodges, E. D.; Harper, James Lloyd; Green, J. G.; Tennant, F.

In: Pediatric dentistry, Vol. 15, No. 4, 01.07.1993, p. 282-287.

Research output: Contribution to journalReview article

Durham, TM, Hodges, ED, Harper, JL, Green, JG & Tennant, F 1993, 'Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor: case report.', Pediatric dentistry, vol. 15, no. 4, pp. 282-287.
Durham, T. M. ; Hodges, E. D. ; Harper, James Lloyd ; Green, J. G. ; Tennant, F. / Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor : case report. In: Pediatric dentistry. 1993 ; Vol. 15, No. 4. pp. 282-287.
@article{39239b705b4f46f584c70d4454d294f9,
title = "Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor: case report.",
abstract = "This report describes identification of Factor VIII inhibitor in a patient who then received immune tolerance therapy. The precipitating event was a traumatic orofacial injury that was nonresponsive to traditional factor-replacement therapies. An inhibitor complicates medical and dental management of the hemophiliac patient because it counteracts usual techniques of hemorrhage control using coagulation agents derived from Factor VIII (Monoclate--Armour, Blue Bell, PA). Successful identification and management of the inhibitor patient require communication and consultation between the physician and dentist, up-to-date knowledge regarding the hemophiliac patient's bleeding and infusion history and aggressive application of local adjunctive hemostatic therapies.",
author = "Durham, {T. M.} and Hodges, {E. D.} and Harper, {James Lloyd} and Green, {J. G.} and F. Tennant",
year = "1993",
month = "7",
day = "1",
language = "English (US)",
volume = "15",
pages = "282--287",
journal = "Pediatric Dentistry",
issn = "0164-1263",
publisher = "American Academy of Pediatric Dentistry",
number = "4",

}

TY - JOUR

T1 - Management of traumatic oral-facial injury in the hemophiliac patient with inhibitor

T2 - case report.

AU - Durham, T. M.

AU - Hodges, E. D.

AU - Harper, James Lloyd

AU - Green, J. G.

AU - Tennant, F.

PY - 1993/7/1

Y1 - 1993/7/1

N2 - This report describes identification of Factor VIII inhibitor in a patient who then received immune tolerance therapy. The precipitating event was a traumatic orofacial injury that was nonresponsive to traditional factor-replacement therapies. An inhibitor complicates medical and dental management of the hemophiliac patient because it counteracts usual techniques of hemorrhage control using coagulation agents derived from Factor VIII (Monoclate--Armour, Blue Bell, PA). Successful identification and management of the inhibitor patient require communication and consultation between the physician and dentist, up-to-date knowledge regarding the hemophiliac patient's bleeding and infusion history and aggressive application of local adjunctive hemostatic therapies.

AB - This report describes identification of Factor VIII inhibitor in a patient who then received immune tolerance therapy. The precipitating event was a traumatic orofacial injury that was nonresponsive to traditional factor-replacement therapies. An inhibitor complicates medical and dental management of the hemophiliac patient because it counteracts usual techniques of hemorrhage control using coagulation agents derived from Factor VIII (Monoclate--Armour, Blue Bell, PA). Successful identification and management of the inhibitor patient require communication and consultation between the physician and dentist, up-to-date knowledge regarding the hemophiliac patient's bleeding and infusion history and aggressive application of local adjunctive hemostatic therapies.

UR - http://www.scopus.com/inward/record.url?scp=0027637016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027637016&partnerID=8YFLogxK

M3 - Review article

VL - 15

SP - 282

EP - 287

JO - Pediatric Dentistry

JF - Pediatric Dentistry

SN - 0164-1263

IS - 4

ER -